首页> 外文OA文献 >Phase II Study of Concurrent Chemoproton Therapy Using Adaptive Planning for Stage III Locally Advanced Non-Small Cell Lung Cancer

【2h】

Phase II Study of Concurrent Chemoproton Therapy Using Adaptive Planning for Stage III Locally Advanced Non-Small Cell Lung Cancer

机译：AIC研究同期化学泊疗法使用Active Drance in III局部晚期非小细胞肺癌的自适应研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
H. Iwata; K. Akita; H. Ogino; Y. Yamaba; Y. Mori; M. Yoshihara; K. Nakajima; S. Hashimoto; Y. Hattori; K. Hayashi; T. Toshito; F. Baba; K. Nakamae; J.E. Mizoe; Y. Shibamoto;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase II Study of Concurrent Chemoproton Therapy Using Adaptive Planning for Stage III Locally Advanced Non-Small Cell Lung Cancer [J] . Iwata H., Akita K., Ogino H., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：AIC研究同期化学泊疗法使用Active Drance in III局部晚期非小细胞肺癌的自适应研究
2. Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group [J] . Costa Rivas M., Huidobro Vence G., Firvida Perez J. L., Clinical & translational oncology : . 2018,第11期

机译：同铂，血岭和胸腔放射治疗局部晚期非小细胞肺癌的同时化学校长：加利西亚肺癌组的II期研究
3. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer. [J] . Lee S, Choi EK, Lee JS, International Journal of Radiation Oncology, Biology, Physics . 2003,第4期

机译：三维共形放疗和同时进行的丝裂霉素-C，长春碱和顺铂化疗的II期研究，用于III期局部晚期，不可切除的非小细胞肺癌。
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
6. GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy [O] . Qing Zhou, Ming Chen, Gang Wu, 2020

机译：Gemstone-301：CS1001的III期临床试验作为局部晚期/不可切除（第III阶段）非小细胞肺癌（NSCLC）在先前同时/顺序化学疗法后没有疾病进展的患者的固结治疗
7. 1255TiP CheckMate 73L: A phase III study comparing nivolumab (NIVO) plus concurrent chemoradiotherapy (CCRT) followed by NIVO ± ipilimumab (IPI) versus CCRT followed by durvalumab (DURV) for previously untreated, locally advanced (LA) stage III non-small cell lung cancer (NSCLC) [O] . D. De Ruysscher, S.S. Ramalingam, J. Urbanic, 2020

机译：1255蒂治疗检测液73L：将Nivolumab（NIVO）加上同时调味疗法（CCRT）的阶段III研究与Nivo±Ipilimumab（IPI）与CCRT接下来是先前未经治疗的，局部晚期（LA）第III阶段非小细胞肺癌（NSCLC）

Phase II Study of Concurrent Chemoproton Therapy Using Adaptive Planning for Stage III Locally Advanced Non-Small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅